News Room

  • Co-Diagnostics, Inc. Reports Q3 Financial Results and Updates Corporate Developments

    Co-Diagnostics, Inc. Reports Q3 Financial Results and Updates Corporate Developments November 15, 2017 07:30 AM Eastern Standard Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or “the Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced corporate developments and financial results for the third quarter of 2017, […]
  • Co-Diagnostics, Inc. Manufacturing Joint Venture Breaks Ground in India

    Co-Diagnostics, Inc. Manufacturing Joint Venture Breaks Ground in India November 07, 2017 07:30 AM Eastern Standard Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, and Synbiotics Limited (“Synbiotics”), a group company of Asence Inc, a U.S. incorporated company specializing […]
  • Co-Diagnostics, Inc. Granted ISO 13485:2016 Certification

    Co-Diagnostics, Inc. Granted ISO 13485:2016 Certification  November 02, 2017 07:30 AM Eastern Daylight Time  SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, has been granted ISO 13485:2016 certification following successful completion of an audit of its quality management […]
  • Co-Diagnostics, Inc. Products to Be Presented at Fair of Havana 2017

    Co-Diagnostics, Inc. Products to Be Presented at Fair of Havana 2017  October 31, 2017 07:30 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced today that its tests for Zika virus, tuberculosis, and other […]
  • Co-Diagnostics, Inc. to Present Zika Tests to Dominican Republic Ministry of Health

    Co-Diagnostics, Inc. to Present Zika Tests to Dominican Republic Ministry of Health October 16, 2017 07:30 AM Eastern Daylight Time SANDY, Utah–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today upcoming meetings with the Ministry of Public Health […]
  • Co-Diagnostics, Inc. to Present at Robins Equity Research Roundup 2017

    Co-Diagnostics, Inc. to Present at Robins Equity Research Roundup 2017 September 25, 2017 07:30 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced today that it will be presenting at the Third Annual Robins […]
  • Co-Diagnostics, Inc. to Present at NewsMakers Conference 2017

    Co-Diagnostics, Inc. to Present at NewsMakers Conference 2017 September 07, 2017 07:30 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced today that CEO Dwight Egan will represent Co-Diagnostics as a Presenting Company at […]
  • Co-Diagnostics, Inc. to Sign Purchase Agreement with MEDCIS Pathlabs

    Co-Diagnostics, Inc. to Sign Purchase Agreement with MEDCIS Pathlabs September 05, 2017 09:31 AM Eastern Daylight Time SANDY, Utah–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, and MEDCIS Pathlabs India Pvt. Ltd., have agreed to the terms of a purchase […]
  • Co-Diagnostics, Inc. Strengthens Zika Customer Base in Caribbean Basin

    Co-Diagnostics, Inc. Strengthens Zika Customer Base in Caribbean Basin Sales expected upon successful performance evaluation and validation August 24, 2017 07:30 AM Eastern Daylight Time SANDY, Utah–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced today that they have strengthened […]
  • Co-Diagnostics, Inc. CEO to Present at 2017 SALSS

    Co-Diagnostics, Inc. CEO to Present at 2017 SALSS August 22, 2017 07:30 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, announced today that CEO Dwight Egan will be a presenter at the 2017 Swedish-American […]
  • Co-Diagnostics, Inc. to Undergo ISO 13485:2016 Audit

    Co-Diagnostics, Inc. to Undergo ISO 13485:2016 Audit Audit to prepare for eventual sales into the US market August 10, 2017 07:30 AM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, will be undergoing a Stage […]
  • Co-Diagnostics, Inc. to Attend AACC 2017

    Co-Diagnostics, Inc. to Attend AACC 2017 August 02, 2017 12:12 PM Eastern Daylight Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company with a unique, proprietary platform for the development of diagnostic tests, will be sending Company representatives on August 2-3, 2017, to attend the 69th AACC Annual Scientific Meeting […]
  • Co-Diagnostics, Inc. Verifies Zika CoPrimer™ Test

    Co-Diagnostics, Inc. Verifies Zika CoPrimer™ Test   SALT LAKE CITY, July 27, 2017 (GLOBE NEWSWIRE) — Co-Diagnostics, Inc. (NASDAQ:CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, has completed principle design and verification of its Zika test built on the Company’s CoPrimer™ technology. The […]
  • Co-Diagnostics, Inc. Announces Joint Venture in India

    Co-Diagnostics, Inc. Announces Joint Venture in India   SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has a unique, proprietary platform for the development of diagnostic tests, officially announced today the recent incorporation of CoSara Diagnostics, Pvt., Ltd., a Joint Venture for manufacturing with Synbiotics Limited. Synbiotics is […]
  • Co-Diagnostics, Inc. to Use IPO Proceeds to Expand Operations

    Co-Diagnostics, Inc. to Use IPO Proceeds to Expand Operations SALT LAKE CITY, UTAH (PRWEB) JULY 17, 2017 Salt Lake City, UT – July 17, 2017 – Co-Diagnostics, Inc. (NASDAQ: CODX) (“Co-Diagnostics” or the “Company”), a molecular diagnostics company that has developed and intends both to manufacture and sell reagents used for diagnostic tests, has completed its […]